Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), bought 158 shares at $40.49 ($6K) on 2022-05-13, disclosed to the SEC on 2022-05-17.
Open-market purchase of $6k TXG by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |